We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+28.18%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$140M
AUM Growth
+$28.6M
(+26%)
Cap. Flow
+$8.22M
Cap. Flow
% of AUM
5.89%
Top 10 Holdings %
Top 10 Hldgs %
33.99%
Holding
146
New
28
Increased
39
Reduced
44
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OptimizeRx
OPRX
|
+$1.61M |
| 2 |
Sensus Healthcare
SRTS
|
+$1.61M |
| 3 |
IZEA Worldwide
IZEA
|
+$1.31M |
| 4 |
Magnite
MGNI
|
+$1.24M |
| 5 |
BioLife Solutions
BLFS
|
+$1.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TBCH
Turtle Beach Corp
TBCH
|
+$3.51M |
| 2 |
Axogen
AXGN
|
+$2.76M |
| 3 |
Blackstone
BX
|
+$1.36M |
| 4 |
Ring Energy
REI
|
+$1.23M |
| 5 |
AllianceBernstein
AB
|
+$1.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.63% |
| 2 | Technology | 13.37% |
| 3 | Industrials | 7.81% |
| 4 | Communication Services | 4.24% |
| 5 | Energy | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Axogen
AXGN
$2.77B
| $18.4M | 13.16% |
365,675
-62,575
| -15% | -$2.76M |
|
2
Vericel Corp
VCEL
$2.1B
| $5.36M | 3.84% |
552,100
+7,150
| +1% | +$89.1K |
|
3
Abbott
ABT
$195B
| $4.7M | 3.37% |
77,050
-3,900
| -5% | -$236K |
|
4
NeoGenomics
NEO
$2.32B
| $3.8M | 2.72% |
289,800
-3,050
| -1% | -$33.6K |
|
5
Idexx Laboratories
IDXX
$43.7B
| $2.91M | 2.08% |
13,350
| – | – |
|
6
Tactile Systems Technology
TCMD
$525M
| $2.74M | 1.96% |
52,624
+1,700
| +3% | +$74K |
|
7
CryoPort
CYRX
$815M
| $2.48M | 1.77% |
156,900
+31,000
| +25% | +$330K |
|
8
CareDx
CDNA
$2.58B
| $2.47M | 1.77% |
201,560
+79,210
| +65% | +$908K |
|
9
Pfizer
PFE
$159B
| $2.44M | 1.75% |
70,796
+2,846
| +4% | +$97.3K |
|
|
CSII
10
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.21M | 1.58% |
68,350
+7,550
| +12% | +$208K |
|
11
LeMaitre Vascular
LMAT
$1.84B
| $2.16M | 1.55% |
64,550
-1,250
| -2% | -$44.5K |
|
12
ANI Pharmaceuticals
ANIP
$1.67B
| $2.07M | 1.48% |
31,000
+4,000
| +15% | +$250K |
|
13
Microsoft
MSFT
$3.81T
| $2.05M | 1.47% |
20,810
-1,000
| -5% | -$96.9K |
|
|
TEUM
14
DELISTED
Pareteum Corporation
TEUM
| $2.05M | 1.47% |
818,729
+245,500
| +43% | +$614K |
|
15
Rockwell Medical
RMTI
$32.9M
| $2.03M | 1.45% |
3,736
-129
| -3% | -$77.4K |
|
16
Eli Lilly
LLY
$1.05T
| $2.02M | 1.44% |
23,610
-1,200
| -5% | -$98.6K |
|
|
TTSH
17
DELISTED
Tile Shop Holdings
TTSH
| $1.96M | 1.41% |
255,000
+138,500
| +119% | +$960K |
|
18
AtriCure
ATRC
$2.47B
| $1.93M | 1.38% |
71,250
-500
| -0.7% | -$11.8K |
|
|
CTLP
19
DELISTED
Cantaloupe
CTLP
| $1.82M | 1.31% |
130,250
+24,550
| +23% | +$279K |
|
|
20
BioLife Solutions
BLFS
$1.78B
| $1.8M | 1.29% |
157,800
+130,300
| +474% | +$1.19M |
|
|
21
Sensus Healthcare
SRTS
$57.9M
| $1.79M | 1.28% |
+246,886
| New | +$1.61M |
|
22
Apyx Medical
APYX
$130M
| $1.74M | 1.25% |
400,700
+146,450
| +58% | +$540K |
|
|
CGRN
23
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $1.65M | 1.18% |
115,214
+7,400
| +7% | +$110K |
|
|
PFIE
24
DELISTED
Profire Energy, Inc
PFIE
| $1.64M | 1.18% |
485,525
-78,856
| -14% | -$318K |
|
|
25
OptimizeRx
OPRX
$150M
| $1.63M | 1.17% |
+157,118
| New | +$1.61M |
|
Similar funds
AA
WA
AC
BCVI
SWM
HAP
RHIG
CWM
Perkins Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Perkins Capital Management held 146 positions worth $140M, up 26% from $111M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Perkins Capital Management deployed $8.22M of net new capital in Q2 2018, opening 28 new positions and adding to 39 existing holdings. Its largest new stake was OptimizeRx: 157,118 shares worth $1.63M.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 57% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Turtle Beach Corp, an estimated $3.51M trimmed.
- Perkins Capital Management's largest Q2 2018 buy was OptimizeRx: 157,118 shares worth $1.63M.
- Perkins Capital Management added most to IZEA Worldwide in Q2 2018, an estimated $1.31M increase.
- Perkins Capital Management's biggest Q2 2018 reduction was Turtle Beach Corp, cutting an estimated $3.51M.
- Perkins Capital Management fully exited Blackstone in Q2 2018, selling an estimated $1.36M.
- Perkins Capital Management's ten largest holdings make up 34% of its $140M portfolio in Q2 2018.
- Perkins Capital Management opened 28 new positions and closed 19 in Q2 2018.
- Perkins Capital Management's portfolio value rose 26% quarter-over-quarter to $140M.
Based on Perkins Capital Management's 13F filing for Q2 2018, filed 2 Aug 2018.